CN101869631B - 排毒眼药 - Google Patents
排毒眼药 Download PDFInfo
- Publication number
- CN101869631B CN101869631B CN 201010214140 CN201010214140A CN101869631B CN 101869631 B CN101869631 B CN 101869631B CN 201010214140 CN201010214140 CN 201010214140 CN 201010214140 A CN201010214140 A CN 201010214140A CN 101869631 B CN101869631 B CN 101869631B
- Authority
- CN
- China
- Prior art keywords
- eyes
- medicament
- toxicant
- elimination
- fructus
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000003814 drug Substances 0.000 title claims abstract description 22
- 210000001508 eye Anatomy 0.000 title claims abstract description 15
- 239000003440 toxic substance Substances 0.000 title claims abstract description 11
- 230000008030 elimination Effects 0.000 title claims abstract description 9
- 238000003379 elimination reaction Methods 0.000 title claims abstract description 9
- 231100000167 toxic agent Toxicity 0.000 title claims abstract description 9
- 229910021538 borax Inorganic materials 0.000 claims abstract description 7
- 239000004328 sodium tetraborate Substances 0.000 claims abstract description 7
- 235000010339 sodium tetraborate Nutrition 0.000 claims abstract description 7
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 claims abstract description 5
- 229940079593 drug Drugs 0.000 claims description 7
- 239000009969 fructus bruceae Substances 0.000 claims description 4
- 230000000694 effects Effects 0.000 abstract description 13
- 208000030533 eye disease Diseases 0.000 abstract description 6
- 208000002177 Cataract Diseases 0.000 abstract description 5
- 208000010412 Glaucoma Diseases 0.000 abstract description 2
- 235000011034 Rubus glaucus Nutrition 0.000 abstract description 2
- 244000235659 Rubus idaeus Species 0.000 abstract description 2
- 235000009122 Rubus idaeus Nutrition 0.000 abstract description 2
- 240000001949 Taraxacum officinale Species 0.000 abstract description 2
- 208000034699 Vitreous floaters Diseases 0.000 abstract description 2
- 230000001954 sterilising effect Effects 0.000 abstract description 2
- 238000004659 sterilization and disinfection Methods 0.000 abstract description 2
- 208000024891 symptom Diseases 0.000 abstract description 2
- 244000247747 Coptis groenlandica Species 0.000 abstract 1
- 235000002991 Coptis groenlandica Nutrition 0.000 abstract 1
- 244000301850 Cupressus sempervirens Species 0.000 abstract 1
- 244000064622 Physalis edulis Species 0.000 abstract 1
- 235000001982 Physalis edulis Nutrition 0.000 abstract 1
- 244000179560 Prunella vulgaris Species 0.000 abstract 1
- 201000002154 Pterygium Diseases 0.000 abstract 1
- 244000097577 Rhus javanica Species 0.000 abstract 1
- 235000010889 Rhus javanica Nutrition 0.000 abstract 1
- 241000207929 Scutellaria Species 0.000 abstract 1
- 235000005187 Taraxacum officinale ssp. officinale Nutrition 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 229940037003 alum Drugs 0.000 abstract 1
- 235000019270 ammonium chloride Nutrition 0.000 abstract 1
- 229940105847 calamine Drugs 0.000 abstract 1
- 229910052864 hemimorphite Inorganic materials 0.000 abstract 1
- 235000008113 selfheal Nutrition 0.000 abstract 1
- 235000014692 zinc oxide Nutrition 0.000 abstract 1
- 239000011787 zinc oxide Substances 0.000 abstract 1
- CPYIZQLXMGRKSW-UHFFFAOYSA-N zinc;iron(3+);oxygen(2-) Chemical compound [O-2].[O-2].[O-2].[O-2].[Fe+3].[Fe+3].[Zn+2] CPYIZQLXMGRKSW-UHFFFAOYSA-N 0.000 abstract 1
- 235000013399 edible fruits Nutrition 0.000 description 6
- 230000006870 function Effects 0.000 description 6
- 230000008961 swelling Effects 0.000 description 6
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 5
- 201000004624 Dermatitis Diseases 0.000 description 5
- 241000196324 Embryophyta Species 0.000 description 5
- 208000002193 Pain Diseases 0.000 description 5
- 208000010668 atopic eczema Diseases 0.000 description 5
- 239000008280 blood Substances 0.000 description 5
- 210000004369 blood Anatomy 0.000 description 5
- 206010023126 Jaundice Diseases 0.000 description 4
- 208000004880 Polyuria Diseases 0.000 description 4
- 208000003251 Pruritus Diseases 0.000 description 4
- 206010047700 Vomiting Diseases 0.000 description 4
- 230000035619 diuresis Effects 0.000 description 4
- 239000000796 flavoring agent Substances 0.000 description 4
- 235000019634 flavors Nutrition 0.000 description 4
- 210000004072 lung Anatomy 0.000 description 4
- 210000002784 stomach Anatomy 0.000 description 4
- 230000008673 vomiting Effects 0.000 description 4
- 206010007247 Carbuncle Diseases 0.000 description 3
- 206010010726 Conjunctival oedema Diseases 0.000 description 3
- 206010011224 Cough Diseases 0.000 description 3
- 206010062717 Increased upper airway secretion Diseases 0.000 description 3
- 241000475481 Nebula Species 0.000 description 3
- 206010040943 Skin Ulcer Diseases 0.000 description 3
- 235000009508 confectionery Nutrition 0.000 description 3
- 238000009826 distribution Methods 0.000 description 3
- 238000001035 drying Methods 0.000 description 3
- 208000001848 dysentery Diseases 0.000 description 3
- 239000003889 eye drop Substances 0.000 description 3
- 230000004438 eyesight Effects 0.000 description 3
- 230000023597 hemostasis Effects 0.000 description 3
- 210000003734 kidney Anatomy 0.000 description 3
- 208000026435 phlegm Diseases 0.000 description 3
- 231100000614 poison Toxicity 0.000 description 3
- 230000001737 promoting effect Effects 0.000 description 3
- 231100000019 skin ulcer Toxicity 0.000 description 3
- BAHMQESJBKGPTE-UHFFFAOYSA-N 1,5,8-trimethyl-3a,4-dihydroazuleno[6,5-b]furan-2,6-dione Chemical compound C1C2OC(=O)C(C)=C2C=C2C(C)=CC(=O)C2=C1C BAHMQESJBKGPTE-UHFFFAOYSA-N 0.000 description 2
- 201000000736 Amenorrhea Diseases 0.000 description 2
- 206010001928 Amenorrhoea Diseases 0.000 description 2
- 206010010741 Conjunctivitis Diseases 0.000 description 2
- 241000201295 Euphrasia Species 0.000 description 2
- 206010017553 Furuncle Diseases 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- 208000037062 Polyps Diseases 0.000 description 2
- 206010067171 Regurgitation Diseases 0.000 description 2
- 241001092459 Rubus Species 0.000 description 2
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 2
- 208000025865 Ulcer Diseases 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 231100000540 amenorrhea Toxicity 0.000 description 2
- 208000002399 aphthous stomatitis Diseases 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 210000000795 conjunctiva Anatomy 0.000 description 2
- 230000001276 controlling effect Effects 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 208000001780 epistaxis Diseases 0.000 description 2
- 229940012356 eye drops Drugs 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 206010022437 insomnia Diseases 0.000 description 2
- 201000007227 lymph node tuberculosis Diseases 0.000 description 2
- 230000014759 maintenance of location Effects 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 230000008520 organization Effects 0.000 description 2
- 244000045947 parasite Species 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 239000011347 resin Substances 0.000 description 2
- 229920005989 resin Polymers 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 231100000397 ulcer Toxicity 0.000 description 2
- 210000002700 urine Anatomy 0.000 description 2
- 206010063409 Acarodermatitis Diseases 0.000 description 1
- 208000030090 Acute Disease Diseases 0.000 description 1
- 241000197194 Bulla Species 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- 239000004099 Chlortetracycline Substances 0.000 description 1
- 206010008631 Cholera Diseases 0.000 description 1
- 244000089795 Clausena lansium Species 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- 208000019505 Deglutition disease Diseases 0.000 description 1
- 206010013954 Dysphoria Diseases 0.000 description 1
- 206010018498 Goitre Diseases 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 206010019345 Heat stroke Diseases 0.000 description 1
- 241000534672 Hiodon alosoides Species 0.000 description 1
- 206010020741 Hyperpyrexia Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 229920001202 Inulin Polymers 0.000 description 1
- 206010024229 Leprosy Diseases 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- 206010059013 Nocturnal emission Diseases 0.000 description 1
- 208000022873 Ocular disease Diseases 0.000 description 1
- 206010068319 Oropharyngeal pain Diseases 0.000 description 1
- 206010033078 Otitis media Diseases 0.000 description 1
- 206010034038 Parotitis Diseases 0.000 description 1
- 201000007100 Pharyngitis Diseases 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 240000003085 Quassia amara Species 0.000 description 1
- 235000009694 Quassia amara Nutrition 0.000 description 1
- 241000447727 Scabies Species 0.000 description 1
- 208000007180 Sunstroke Diseases 0.000 description 1
- 206010042674 Swelling Diseases 0.000 description 1
- 206010043458 Thirst Diseases 0.000 description 1
- 208000002474 Tinea Diseases 0.000 description 1
- 241000130764 Tinea Species 0.000 description 1
- 208000007712 Tinea Versicolor Diseases 0.000 description 1
- 206010056131 Tinea versicolour Diseases 0.000 description 1
- 206010064996 Ulcerative keratitis Diseases 0.000 description 1
- 208000003443 Unconsciousness Diseases 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 206010053692 Wound complication Diseases 0.000 description 1
- 206010051373 Wound haemorrhage Diseases 0.000 description 1
- PGTXKIZLOWULDJ-UHFFFAOYSA-N [Mg].[Zn] Chemical compound [Mg].[Zn] PGTXKIZLOWULDJ-UHFFFAOYSA-N 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 206010001093 acute tonsillitis Diseases 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000001142 anti-diarrhea Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000001139 anti-pruritic effect Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 239000004599 antimicrobial Substances 0.000 description 1
- 239000003908 antipruritic agent Substances 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 208000010217 blepharitis Diseases 0.000 description 1
- 208000002352 blister Diseases 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 210000005252 bulbus oculi Anatomy 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- CYDMQBQPVICBEU-UHFFFAOYSA-N chlorotetracycline Natural products C1=CC(Cl)=C2C(O)(C)C3CC4C(N(C)C)C(O)=C(C(N)=O)C(=O)C4(O)C(O)=C3C(=O)C2=C1O CYDMQBQPVICBEU-UHFFFAOYSA-N 0.000 description 1
- 229960004475 chlortetracycline Drugs 0.000 description 1
- CYDMQBQPVICBEU-XRNKAMNCSA-N chlortetracycline Chemical compound C1=CC(Cl)=C2[C@](O)(C)[C@H]3C[C@H]4[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]4(O)C(O)=C3C(=O)C2=C1O CYDMQBQPVICBEU-XRNKAMNCSA-N 0.000 description 1
- 235000019365 chlortetracycline Nutrition 0.000 description 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
- 229960001231 choline Drugs 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 201000007717 corneal ulcer Diseases 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 239000000645 desinfectant Substances 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 206010013990 dysuria Diseases 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 206010015037 epilepsy Diseases 0.000 description 1
- 239000003172 expectorant agent Substances 0.000 description 1
- 230000003419 expectorant effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000003885 eye ointment Substances 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 230000001605 fetal effect Effects 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 208000007565 gingivitis Diseases 0.000 description 1
- 201000003872 goiter Diseases 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 208000035861 hematochezia Diseases 0.000 description 1
- 208000006750 hematuria Diseases 0.000 description 1
- 208000021760 high fever Diseases 0.000 description 1
- 208000013403 hyperactivity Diseases 0.000 description 1
- 210000003026 hypopharynx Anatomy 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 201000001371 inclusion conjunctivitis Diseases 0.000 description 1
- 206010022000 influenza Diseases 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 239000002917 insecticide Substances 0.000 description 1
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 description 1
- 229940029339 inulin Drugs 0.000 description 1
- 206010023332 keratitis Diseases 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 230000003211 malignant effect Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 208000004396 mastitis Diseases 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 208000001491 myopia Diseases 0.000 description 1
- 230000004379 myopia Effects 0.000 description 1
- 230000008693 nausea Effects 0.000 description 1
- 231100000344 non-irritating Toxicity 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 230000000050 nutritive effect Effects 0.000 description 1
- 201000005737 orchitis Diseases 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 201000010041 presbyopia Diseases 0.000 description 1
- 210000002307 prostate Anatomy 0.000 description 1
- 239000003223 protective agent Substances 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 229940013788 quassia Drugs 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 239000004576 sand Substances 0.000 description 1
- 208000005687 scabies Diseases 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 210000000582 semen Anatomy 0.000 description 1
- 201000008525 senile cataract Diseases 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 235000019615 sensations Nutrition 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 230000003068 static effect Effects 0.000 description 1
- 230000004206 stomach function Effects 0.000 description 1
- 208000003265 stomatitis Diseases 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 229940124530 sulfonamide Drugs 0.000 description 1
- 150000003456 sulfonamides Chemical class 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 208000004371 toothache Diseases 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 206010044325 trachoma Diseases 0.000 description 1
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 1
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 210000003905 vulva Anatomy 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
本发明公开了一种排毒眼药,该排毒眼药的原料药按重量百分比由以下组分组成:6%的黄柏、6%的黄芩、6%的黄连、6%的夏枯草、6%的灯笼草、6%的草血竭、6%的苦参、14%的鸭胆子、6%的覆盆子、6%的蒲公英、6%的琥珀、3%的枯矾、3%的硼砂、2%的硇砂、18%的炉甘石。本发明具有祛毒、排毒立竿见影的功效;具有杀菌、消炎、功效,能使眼疾达到康复,疗效独特。适用于青光眼、白内障、飞蚊症、攀金眼等眼疾患者。
Description
技术领域
本发明涉及一种排毒眼药。
背景技术
眼睛是人类极其重要的器官,为了保护眼睛和治疗眼睛的疾病,千百年来,人们采用了许多方法和研究了种种药物,对近视、老花等眼疾进行防治,对砂眼、白内障、结膜炎、角膜炎等眼病进行治疗,在治疗过程中,除了用抗菌素、消炎药等内服药物外,人们也研制出许多眼药水,直接滴入眼内,如人们常用的氯素眼药水、金霉素眼药水、珍珠滴眼液、磺胺类眼药水等,上述眼药水可以不同程度的分别治疗沙眼、结膜炎、角膜溃疡、眼球炎、老年性白内障等一些眼睛疾病,但是也存在一些不足之处,如有的粘度太大,容易遮挡视线,有的治疗效果欠佳,多数眼病患者,均需滴眼液、眼膏同时使用来治一种眼病,给患者带来诸多不便,大部分具有明显的副作用,疗效不佳。
发明内容
本发明要解决的技术问题是:为了弥补目前眼药水存在的不足,提供了一种无刺激性的速效眼药水。
本发明的技术方案是通过如下方式实现的:该排毒眼药的原料药按重量百分比由以下组分组成:6%的黄柏、6%的黄芩、6%的黄连、6%的夏枯草、6%的灯笼草、6%的草血竭、6%的苦参、14%的鸭胆子、6%的覆盆子、6%的蒲公英、6%的琥珀、3%的枯矾、3%的硼砂、2%的硇砂、18%的炉甘石。
本发明实现的技术效果是:具有祛毒、排毒立竿见影的功效; 以及具有杀菌、消炎、功效,能使眼疾达到康复,并且可以作为伤口止痛生肌外用药,疗效独特。即使长期使用对人体也无刺激,彻底解决了多年来困扰眼病治疗的难题,有利于对局部组织的修复,并能提高局部组织自身的免疫力和抗病力。
本品适用于青光眼、白内障、飞蚊症、攀金眼等眼疾患者,可谓药到病除。
黄柏,为芸香科植物黄皮树或黄檗的干燥树皮。前者习称“川黄柏”,后者习称“关黄柏”。可入药,性味苦寒,有清热燥湿,泻火除蒸,解毒疗疮之功效。
黄芩,清热燥湿,泻火解毒,止血,安胎。用于湿温、暑温胸闷呕恶,湿热痞满,泻痢,黄疸,肺热咳嗽,高热烦渴,血热吐衄,痈肿疮毒,胎动不安。
黄连,用于湿热痞满,呕吐吞酸,泻痢,黄疸,高热神昏,心火亢盛,心烦不寐,血热吐衄,目赤,牙痛,消渴,痈肿疔疮;外治湿疹,湿疮,耳道流脓,酒黄连善清上焦火热,用于目赤,口疮。姜黄连清胃和胃止呕,寒热互结,湿热中阻,痞满呕吐。
夏枯草,苦、辛,寒。①清火明目,治目赤肿痛、头痛。②清肝火、降血压,治高血压病。③散结消肿,治瘰疬、瘿瘤、乳痈肿痛。
灯笼草,苦,微寒,归肺经,清热解毒,利尿去湿, 用于癍痧发热,感冒,腮腺炎,喉痛,咳嗽,睾丸炎,大疱疮。常用量15~30克;外用适量。
草血竭,微温,苦辛微涩,性凉,味酸,无毒,入脾,胃,肾三经。活血散瘀,止痛,止血,外用治创伤出血。
苦参,为豆科苦参属的植物,功能主治:清热燥湿,杀虫,利尿,用于热痢,便血,黄疸尿闭,赤白带下,阴肿阴痒,湿疹,湿疮,皮肤瘙痒,疥癣麻风。
鸭胆子,别名为苦参子,本品为苦木科植物,鸭胆子树的成熟种子,苦,寒,入大肠经。
覆盆子,是一种蔷薇科悬钩子属的木本植物,是一种水果,果实味道酸甜,植株的枝干上长有倒钩刺;覆盆子的果实是一种聚合果,有红色,金色和黑色,在欧美作为水果,在中国大量分布但少为人知,仅在东北地区有少量栽培,市场上比较少见;覆盆子植物可入药,有多种药物价值,其果实有补肾壮阳的作用;覆盆子油属于不饱和脂肪酸,可促进前列腺分泌苛尔蒙。功用主治:补肝肾,缩小便,助阳,固精,明目。
蒲公英,蒲公英属菊科多年生草本植物;蒲公英植物体中含有蒲公英醇、蒲公英素、胆碱、有机酸、菊糖等多种健康营养成分,有利尿、缓泻、退黄疸、利胆等功效。蒲公英同时含有蛋白质、脂肪、碳水化合物、微量元素及维生素等,有丰富的营养价值,可生吃、炒食、做汤,是药食兼用的植 物。
琥珀,是数千万年前的树脂被埋藏于地下,经过一定的化学变化后形成的一种树脂化石,是一种有机的似矿物;琥珀的形状多种多样,表面常保留着当初树脂流动时产生的纹路,内部经常可见气泡及古老昆虫或植物碎屑,性味归经,甘,平。功能主治:镇静,利尿,活血。用于惊风,癫痫,心悸,失眠,小便不利,尿痛,尿血,闭经。
枯矾,又名煅白矾。取拣净的白矾,置砂锅内加热溶化并煅至枯干,取出。功能主治:消痰,燥湿,止泻,止血,解毒,杀虫。
硼砂也叫粗硼砂,是一种既软又轻的无色结晶物质。硼砂有着很多用途我们熟悉的如消毒剂、保鲜防腐剂、软水剂、洗眼水、肥皂添加剂、陶瓷的釉料和玻璃原料等,在工业生产中硼砂也有着重要的作用。性味归经:甘、咸,凉。归肺、胃经。 功能主治:外用清热解毒,消肿,防腐;内服清肺化痰。用于急性扁桃体炎,咽喉炎,咽喉肿痛,口舌生疮,口腔炎,齿龈炎,中耳炎,目赤肿痛,汗斑,为五官科疾患的常用药;内服用于痰热咳嗽。
硇砂,主要用于消积软坚,破瘀散结。治症瘕痃癣,噎膈反胃,痰饮,喉痹,积痢,经闭,目翳,息肉,疣赘,疔疮,瘰疬,痈肿,恶疮。
炉甘石,为不溶于水的天然碳酸锌,广用于皮肤科, 作为中度的防腐、收敛、保护剂治疗皮肤炎症或表面创伤。外用可抑制局部葡萄球菌生长。能部分吸收创面分泌液,有收敛、保护作用;性味甘,平,归胃经。解毒明目退翳,收湿止痒敛疮。用于目赤肿痛,眼缘赤烂,翳膜胬肉,溃疡不敛,脓水淋漓,湿疮,皮肤瘙痒。
具体实施方式
首先称取按重量百分比由以下组分组成的配伍原料:6%的黄柏、6%的黄芩、6%的黄连、6%的夏枯草、6%的灯笼草、6%的草血竭、6%的苦参、14%的鸭胆子、6%的覆盆子、6%的蒲公英、6%的琥珀、3%的枯矾、3%的硼砂、2%的硇砂、18%的炉甘石,其次是将配伍原料先后放入密封容器中浸泡24小时,最后过滤并将过滤后的液体装瓶即可使用。
本发明人用三年时间先后选择共100例治疗组和同类其它药物对照组进行临床效果实验,其中治疗组70例,对照组为30例。实验结果表明:在治疗组70例中,65人有效,有效率达92.9%;对照组为30例,20人有效,有效率仅为66.7%。
典型病例:
1、张庆彦,男,三十八岁,宁陵县张弓镇张庄村人,眼睛失明多年,用此药3个疗程后得到了明显改善,现在已经复明。
2、王传名,男,五十五岁,睢阳区人,患白内障, 用四瓶后明显好转。
3、董玉兴,男,四十四岁,柘城县佰岗乡董楼村,眼睛流泪多年,在许多医院诊治,效果不佳,使用本品4瓶后全愈。
4、王风芝,女,六十五岁,民权县野岗乡雷庄村,双眼结膜,充血红肿、瘙痒,有异物感,用珍珠明目眼药水治疗无效后,用本眼药水治疗,3天痊愈。
Claims (1)
1.一种排毒眼药,其特征在于,该排毒眼药的原料药按重量百分比由以下组分组成:6%的黄柏、6%的黄芩、6%的黄连、6%的夏枯草、6%的灯笼草、6%的草血竭、6%的苦参、14%的鸭胆子、6%的覆盆子、6%的蒲公英、6%的琥珀、3%的枯矾、3%的硼砂、2%的硇砂、18%的炉甘石。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 201010214140 CN101869631B (zh) | 2010-06-25 | 2010-06-25 | 排毒眼药 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 201010214140 CN101869631B (zh) | 2010-06-25 | 2010-06-25 | 排毒眼药 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101869631A CN101869631A (zh) | 2010-10-27 |
CN101869631B true CN101869631B (zh) | 2011-09-14 |
Family
ID=42994837
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 201010214140 Expired - Fee Related CN101869631B (zh) | 2010-06-25 | 2010-06-25 | 排毒眼药 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101869631B (zh) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105250520A (zh) * | 2015-10-24 | 2016-01-20 | 黄宇松 | 一种治疗白内障的药物组合物 |
CN115887531A (zh) * | 2022-12-13 | 2023-04-04 | 刘健 | 一种治疗眼部疾病的中药组合物 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1205209A (zh) * | 1997-07-14 | 1999-01-20 | 沈阳王朝医药保健品公司 | 置于眼袋中的明目中药及制备方法 |
CN101121012B (zh) * | 2007-08-08 | 2010-05-19 | 李金山 | 一种治疗外障眼睛疾病的中药 |
-
2010
- 2010-06-25 CN CN 201010214140 patent/CN101869631B/zh not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CN101869631A (zh) | 2010-10-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101279027B (zh) | 一种治疗急性结膜炎的中药洗剂制备方法 | |
CN102526441B (zh) | 一种专治妇科炎症的中药冲洗液 | |
CN103768283A (zh) | 一种治疗多种眼疾的中药 | |
CN105213941A (zh) | 一种用于治疗小儿腹泻的中药组合物及其制备方法 | |
CN102614413B (zh) | 一种治疗小儿鼻窦炎的中药组合物及其制备方法 | |
CN102319323B (zh) | 一种降低眼压治疗青光眼的眼药水及其制备方法 | |
CN106334107A (zh) | 一种中药眼药水及其制备方法 | |
CN105106318A (zh) | 一种治疗干眼症的中药组合物及其制备方法 | |
CN101869631B (zh) | 排毒眼药 | |
CN104606615A (zh) | 一种治疗眼部炎症的中药滴眼液及其制备方法 | |
CN104127702A (zh) | 一种治疗急性视神经炎的中药制剂及其制备方法 | |
CN103520649B (zh) | 治疗面部神经炎的中药 | |
CN105125630A (zh) | 一种眼药水及制备方法 | |
CN1160091C (zh) | 一种治疗结膜炎和角膜炎的药物 | |
CN104189307A (zh) | 一种治疗耳聋耳鸣的中药及其制备方法 | |
CN102755549B (zh) | 一种治疗白内障的药物及其制备方法 | |
CN106344827A (zh) | 治疗老花眼的眼药水及其制备方法 | |
CN104983972A (zh) | 一种治疗麦粒肿的滴剂及其制备方法 | |
CN104225569A (zh) | 一种治疗慢性肠炎的中药组合物 | |
CN102940753A (zh) | 一种治疗青光眼的药丸及制备方法 | |
CN104027464B (zh) | 一种治疗慢性结膜炎的中药药剂及其制备方法 | |
CN109793866A (zh) | 一种治疗男性前列腺疾病的中药及制备方法 | |
CN1059345C (zh) | 治疗近视眼的外用药 | |
CN106309779A (zh) | 具有舒缓视疲劳的眼药水及其制备方法 | |
CN104771638A (zh) | 用于治疗视神经萎缩的中药组合物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20110914 Termination date: 20140625 |
|
EXPY | Termination of patent right or utility model |